BRG1 is indispensable for IFN-γ-induced TRIM22 expression, which is dependent on the recruitment of IRF-1

Biochemical and Biophysical Research Communications

Volumn 410, Issue 3, 2011, Pages 549-554

  Wang, Yaxin ^a   Gao, Bo ^a   Xu, Wei ^a   Xiong, Sidong ^a,b  

^a FUDAN UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

BRG1; IFN ; IRF 1; Recruitment; TRIM22

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BRG1 PROTEIN; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; PROTEIN; TRIM22 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CELL STIMULATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; GENE; HUMAN; HUMAN CELL; IN VIVO STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

CELL LINE, TUMOR; CHROMATIN; DNA HELICASES; GENE EXPRESSION REGULATION; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON-GAMMA; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS;

EID: 79960049836     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.06.022     Document Type: Article

References (35)

1. Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L., Riganelli D., Zanaria E., Messali S., Cainarca S., Guffanti A., Minucci S., Pelicci P.G., Ballabio A. The tripartite motif family identifies cell compartments. EMBO J. 2001, 20:2140-2151.
2. Nisole S., Stoye J.P., Saib A. TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 2005, 3:799-808.
3. Ozato K., Shin D.M., Chang T.H., Morse H.C. TRIM family proteins and their emerging roles in innate immunity. Nat. Rev. Immunol. 2008, 8:849-860.
4. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427:848-853.
5. Tissot C., Mechti N. Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression. J. Biol. Chem. 1995, 270:14891-14898.
6. Barr S.D., Smiley J.R., Bushman F.D. The interferon response inhibits HIV particle production by induction of TRIM22. PLoS Pathog. 2008, 4:e1000007.
7. Singh R., Gaiha G., Werner L., McKim K., Mlisana K., Luban J., Walker B.D., Karim S.S., Brass A.L., Ndung'u T. Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection. J. Virol. 2011, 85:208-216.
8. Gao B., Duan Z., Xu W., Xiong S. Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain. Hepatology 2009, 50:424-433.
9. Duan Z., Gao B., Xu W., Xiong S. Identification of TRIM22 as a RING finger E3 ubiquitin ligase. Biochem. Biophys. Res. Commun. 2008, 374:502-506.
10. Eldin P., Papon L., Oteiza A., Brocchi E., Lawson T.G., Mechti N. TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus. J. Gen. Virol. 2009, 90:536-545.
11. Boehm U., Klamp T., Groot M., Howard J.C. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 1997, 15:749-795.
12. van Boxel-Dezaire A.H., Stark G.R. Cell type-specific signaling in response to interferon-gamma. Curr. Top. Microbiol. Immunol. 2007, 316:119-154.
13. Ganem D., Prince A.M. Hepatitis B virus infection-natural history and clinical consequences. N. Engl. J. Med. 2004, 350:1118-1129.
14. Wieland S., Thimme R., Purcell R.H., Chisari F.V. Genomic analysis of the host response to hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 2004, 101:6669-6674.
15. Gao B., Wang Y., Xu W., Duan Z., Xiong S. A 5′ extended IFN-stimulating response element is crucial for IFN-gamma-induced tripartite motif 22 expression via interaction with IFN regulatory factor-1. J. Immunol. 2010, 185:2314-2323.
16. Christova R., Jones T., Wu P.J., Bolzer A., Costa-Pereira A.P., Watling D., Kerr I.M., Sheer D. P-STAT1 mediates higher-order chromatin remodelling of the human MHC in response to IFNgamma. J. Cell Sci. 2007, 120:3262-3270.
17. Guo J.J., Li Q.L., Zhang J., Huang A.L. Histone deacetylation is involved in activation of CXCL10 upon IFNgamma stimulation. Mol. Cell 2006, 22:163-167.
18. Ni Z., Abou El Hassan M., Xu Z., Yu T., Bremner R. The chromatin-remodeling enzyme BRG1 coordinates CIITA induction through many interdependent distal enhancers. Nat. Immunol. 2008, 9:785-793.
19. Chi T. A BAF-centred view of the immune system. Nat. Rev. Immunol. 2004, 4:965-977.
20. Kwon C.S., Wagner D. Unwinding chromatin for development and growth: a few genes at a time. Trends Genet. 2007, 23:403-412.
21. Subtil-Rodriguez A., Reyes J.C. BRG1 helps RNA polymerase II to overcome a nucleosomal barrier during elongation, in vivo. EMBO Rep. 2010, 11:751-757.
22. Liu N., Balliano A., Hayes J.J. Mechanism(s) of SWI/SNF-induced nucleosome mobilization. ChemBioChem 2011, 12:196-204.
23. Pattenden S.G., Klose R., Karaskov E., Bremner R. Interferon-gamma-induced chromatin remodeling at the CIITA locus is BRG1 dependent. EMBO J. 2002, 21:1978-1986.
24. Ni Z., Karaskov E., Yu T., Callaghan S.M., Der S., Park D.S., Xu Z., Pattenden S.G., Bremner R. Apical role for BRG1 in cytokine-induced promoter assembly. Proc. Natl. Acad. Sci. USA 2005, 102:14611-14616.
25. Zhang Y., Cheng M.B., Zhang Y.J., Zhong X., Dai H., Yan L., Wu N.H., Zhang Y., Shen Y.F. A switch from hBrm to Brg1 at IFNg-activated sequences mediates the activation of human genes. Cell Res. 2010, 20:1345-1360.
26. Khavari P.A., Peterson C.L., Tamkun J.W., Mendel D.B., Crabtree G.R. BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature 1993, 366:170-174.
27. Reisman D., Glaros S., Thompson E.A. The SWI/SNF complex and cancer. Oncogene 2009, 28:1653-1668.
28. Alessio N., Squillaro T., Cipollaro M., Bagella L., Giordano A., Galderisi U. The BRG1 ATPase of chromatin remodeling complexes is involved in modulation of mesenchymal stem cell senescence through RB-P53 pathways. Oncogene 2010, 29:5452-5463.
29. Cui K., Tailor P., Liu H., Chen X., Ozato K., Zhao K. The chromatin-remodeling BAF complex mediates cellular antiviral activities by promoter priming. Mol. Cell. Biol. 2004, 24:4476-4486.
30. Cohet N., Stewart K.M., Mudhasani R., Asirvatham A.J., Mallappa C., Imbalzano K.M., Weaver V.M., Imbalzano A.N., Nickerson J.A. SWI/SNF chromatin remodeling enzyme ATPases promote cell proliferation in normal mammary epithelial cells. J. Cell Physiol. 2010, 223:667-678.
31. Hargreaves D.C., Crabtree G.R. ATP-dependent chromatin remodeling: genetics, genomics and mechanisms. Cell Res. 2011, 21:396-420.
32. Carthagena L., Bergamaschi A., Luna J.M., David A., Uchil P.D., et al. Human TRIM gene expression in response to interferons. PLoS One 2009, 4:e4894.
33. Gongora C., Degols G., Espert L., Hua T.D., Mechti N. A unique ISRE, in the TATA-less human Isg20 promoter, confers IRF-1-mediated responsiveness to both interferon type I and type II. Nucleic Acids Res. 2000, 28:2333-2341.
34. Su Z.Z., Sarkar D., Emdad L., Barral P.M., Fisher P.B. Central role of interferon regulatory factor-1 (IRF-1) in controlling retinoic acid inducible gene-I (RIG-I) expression. J. Cell. Physiol. 2007, 213:502-510.
35. Chen C.J., Lin T.T., Shively J.E. Role of interferon regulatory factor-1 in the induction of biliary glycoprotein (cell CAM-1) by interferon-gamma. J. Biol. Chem. 1996, 271:28181-28188.